[ad_1]
G42 Healthcare, a leading artificial intelligence health technology company headquartered in Abu Dhabi, has announced a strategic cooperation with Israel-based Sheba Medical Center to carry out joint research projects and clinical trials in the UAE and Israel in the future.
G42 Healthcare will cooperate with Sheba Medical Centre, one of the top 10 hospitals in the world, in terms of artificial intelligence-driven research projects, infrastructure construction and cooperation solutions to promote cardiology, oncology, obstetrics, gynecology, etc. fields of healthcare, diabetes and fertility to shape the future of healthcare in both countries.
The collaboration underscores the joint efforts and cooperation in medical research and healthcare technology following the signing of the Abraham Accords in 2020 between the UAE, Bahrain, Israel and the United States, and will also focus on major healthcare investments and the introduction of cutting-edge innovations in The healthcare sector in the UAE and Israel.
Clinical Trials
One of the key aspects of the collaboration will focus on leveraging the capabilities of G42 Healthcare’s Insights Research Organization and Solutions [IROS]the first contract research organization based in the UAE [CRO] Focus on different areas of healthcare research, including real-world evidence and clinical trials in all therapeutic areas.
Ashish Koshy, CEO of G42 Healthcare, recently signed a strategic agreement with Prof. Yitshak Kreiss, Director of Sheba Medical Center at G42 Healthcare’s offices in Masdar City, Abu Dhabi.
Commenting on the collaboration, G42 Healthcare CEO Ashish Koshy said: “As part of our collaboration with Sheba, we look forward to utilizing our state-of-the-art research capabilities and breakthrough technologies to support scientific and ethical research, conduct clinical trials and report, Expanding and ensuring access to innovations that change life-changing treatments. We envision a world where healthcare can be realized to its fullest potential by encouraging prevention over cure and unlocking the potential to transform the traditional healthcare ecosystem by unlocking the potential of personalized and preventive care.”
improve care
Commenting, Professor Yitshak Kreiss, Director General of Sheba Medical Center said: “In line with Sheba Medical Center’s commitment to delivering ‘hope without boundaries’, improving care and supporting patients in their most complex situations, we were always looking for impactful collaborations. We are delighted Partnering with G42 Healthcare to accelerate clinical research, increase patient access to new treatments and help improve patient outcomes, with a focus on creating a better quality of life.”
With Sheba, G42 Healthcare will leverage IROS’ real-world data and AI-enabled services to support leading international clinical research standards. IROS provides clinical trial services including clinical project management, data management, medical writing and laboratory services, as well as technology solutions for RWE and RWD.
IROS is committed to providing intelligent and high-quality solutions to help develop new medicines and medicines by utilizing state-of-the-art research capabilities and breakthrough technologies to inspire the generation of revolutionary treatments to address pressing healthcare challenges of the present and the future. G42 Healthcare and Sheba Medical Center aim to leverage these capabilities for clinical trials and joint research projects in both countries. — trade arab news agency
[ad_2]
Source link